Skip to content

Patients › Hand

Dedo em gatilho

Trigger finger causes painful catching or locking of a finger, often treated with splinting or steroid injection.

Updated Oct 2026
Ilustração desenhada à mão de uma mão com um dedo preso dobrado, enganchando ao se esticar.
Dedo em gatilho: o dedo engancha ou trava ao dobrar. Kieran Hirpara 4.0

Esta página foi traduzida automaticamente e ainda não foi verificada por um médico. A versão em inglês é a versão oficial.

O que você está sentindo

O dedo em gatilho afeta os tendões que dobram o dedo ou o polegar. Esses tendões deslizam por um túnel estreito na palma da mão, chamado polia. Quando o tendão fica espessado, ele engancha ao passar por esse túnel. Você sente dor e sensibilidade na palma da mão, na base do dedo ou polegar afetado. Algumas pessoas notam ali, na palma, um pequeno nódulo ou caroço. Esse nódulo é a parte espessada do tendão ou do seu túnel, e ele se move junto com o tendão.

O enganchamento geralmente começa como um leve incômodo e vai piorando ao longo de semanas. No início, o dedo pode fazer um clique ou enganchar quando você o dobra e o estica, e talvez você precise endireitá-lo com a outra mão. À medida que piora, o dedo pode travar na posição dobrada e permanecer assim. Muitas pessoas percebem que ele fica mais rígido ao acordar e vai se soltando à medida que se movimentam ao longo do dia. Apertar e fazer movimentos de pinça é o que agrava o problema, por isso tarefas como segurar o volante, carregar sacolas de compras, usar tesoura ou segurar com força a tampa de um pote podem ficar desconfortáveis. Algumas pessoas também sentem dor no dorso do nó do dedo ou da articulação do meio do mesmo dedo, embora o problema esteja na palma da mão.

O dedo em gatilho é comum. Afeta de 2% a 3% das pessoas, as mulheres com mais frequência do que os homens, e geralmente aparece depois dos 45 anos. Se mais de um dedo apresentar gatilho, vale a pena mencionar isso ao seu cirurgião, pois pode haver relação com outras condições, como o diabetes. O dedo em gatilho também costuma ocorrer junto com a síndrome do túnel do carpo, que causa formigamento ou dormência na mão, e as duas condições aparecem juntas em 40% a 60% das pessoas com dedo em gatilho.

Consulte o seu médico de família ou peça uma avaliação com especialista se os seus sintomas não estiverem melhorando, estiverem piorando ao longo de semanas, acordarem você à noite ou impedirem você de trabalhar ou de usar a mão.

O que realmente está acontecendo

Os tendões que dobram o seu dedo são como cordas que passam por um conjunto de alças-guia na palma da mão e no dedo. A primeira dessas alças fica na palma, na base do dedo. Ela se chama polia A1. Quando você segura ou aperta algo repetidamente, o tendão pode ficar irritado no ponto em que desliza por essa alça. A área irritada fica espessada, e a corda deixa de deslizar suavemente. Em vez disso, ela se embola e depois força a passagem pela alça estreitada, e é isso o enganchamento ou estalo que você sente.

O ponto espessado no tendão costuma ser um pequeno nódulo, um nó de tecido alterado um pouco mais largo do que o restante da corda. Cada vez que você dobra o dedo, esse nó precisa passar apertado por baixo da polia. Ele passa com um clique e depois engancha do outro lado quando você tenta esticar o dedo. É por isso que o dedo pode travar na posição dobrada e precisar da outra mão para se soltar, e é por isso que o problema parece pior pela manhã, depois de uma noite com o dedo em repouso na posição dobrada.

Os médicos descrevem o quanto a condição avançou em quatro estágios. O primeiro é dor e sensibilidade na palma da mão, na altura dessa primeira alça. O segundo acrescenta o enganchamento do dedo. O terceiro é o travamento que você ainda consegue desfazer esticando o dedo com a ajuda da outra mão. O quarto é um dedo preso na posição dobrada que não pode mais ser esticado de forma alguma. Os estágios iniciais costumam melhorar com tratamentos mais simples, enquanto um dedo travado geralmente precisa de um pequeno procedimento para abrir a polia, para que o tendão volte a deslizar.

Vários fatores tornam esse espessamento mais provável. Apertos firmes e repetidos têm um papel, e é por isso que ele é comum em remadores e em outras pessoas que sobrecarregam muito a força de preensão. Ele também está relacionado a condições como diabetes, tireoide hipoativa, gota e artrite reumatoide, em que o tecido ao redor do tendão fica inflamado ou se altera de maneiras que estreitam o túnel. Se vários dedos apresentarem gatilho ao mesmo tempo, vale a pena chamar a atenção para esse padrão, pois ele pode indicar uma dessas condições subjacentes.

O que podemos fazer a respeito

O Dr. Kieran Hirpara, cirurgião de membros superiores no Mater Private Hospital Rockhampton, começa com as opções menos invasivas adequadas ao seu quadro clínico. Em geral, os pacientes são encaminhados à nossa clínica pelo médico de família; caso um fisioterapeuta tenha sugerido que você nos procure, ainda assim será necessário um encaminhamento do seu médico de família para que você tenha direito ao reembolso do Medicare. Na sua consulta, colhemos o histórico clínico, examinamos a sua mão e solicitamos exames de imagem apenas se eles forem mudar o plano de tratamento. Para um problema de longa duração como este, geralmente tentamos primeiro o tratamento não cirúrgico e consideramos a cirurgia quando ele não trouxe melhora suficiente.

O primeiro passo é acalmar a sua mão. Mudar a forma como você segura os objetos e reduzir as tarefas que sobrecarregam a palma da mão, como carregar peso ou apertar com força, dá ao tendão irritado a chance de se acalmar. A terapia da mão visa restaurar o deslizamento suave do tendão pela polia e manter as articulações do dedo em movimento. Uma tala que mantém o dedo imóvel pode fazer parte disso, e ela funciona melhor quando usada por tempo suficiente: manter uma única articulação imóvel por 6 a 10 semanas é a duração respaldada pelas evidências, o que é mais tempo do que a maioria das pessoas imagina. Dê a essas medidas um período de teste adequado, de várias semanas, antes de avaliar o resultado.

Se as medidas simples não resolverem, uma injeção de cortisona no túnel do tendão é o próximo passo habitual. A cortisona reduz o inchaço e o espessamento que fazem o tendão enganchar. Pessoas com diabetes tendem a responder menos bem às injeções de cortisona, o que vale a pena saber na hora de escolher entre as opções. A maioria das pessoas espera que a injeção doa mais do que realmente dói e, depois, diz que foi mais fácil do que esperava.

A cirurgia entra em cena quando o dedo continua travado ou quando as injeções e a tala não trouxeram melhora suficiente. A operação libera a polia apertada na base do dedo para que o tendão volte a deslizar livremente. Ela é feita por meio de uma pequena incisão na palma da mão e é um procedimento simples e bem estabelecido. Conversaremos sobre se ela é adequada para você e decidiremos juntos. Depois, a sua reabilitação é feita com terapia da mão, com Ruby Doolan, da Extend Rehabilitation; ela vai orientar os seus exercícios e confeccionar qualquer tala de que você precise.

O que esperar

O dedo em gatilho raramente volta ao normal sozinho depois que o dedo começa a enganchar ou travar. No início, quando há apenas dor e sensibilidade na palma da mão, tratamentos mais simples, como mudar a forma de segurar os objetos, terapia da mão e uma tala, podem acalmar o problema. A tala precisa ser usada por tempo suficiente para funcionar: para uma única articulação, 6 a 10 semanas é a duração respaldada pelas evidências. Se essas medidas não ajudarem, uma injeção de cortisona no túnel do tendão resolve o problema em pouco mais da metade das pessoas, e é por isso que uma segunda injeção ou a passagem para a cirurgia é um próximo passo normal, e não um sinal de que algo deu errado.

Quando o dedo chega ao estágio de travamento, a liberação da polia apertada é o tratamento que atua na causa. O tendão volta então a deslizar pelo túnel, e o uso normal do dedo ou do polegar é incentivado depois. A maioria das pessoas fica contente por ter feito o procedimento. Ainda assim, é justo conhecer os detalhes. Cerca de 1 em cada 20 dedos tem depois um problema leve e passageiro, na maioria das vezes dor, rigidez ou inchaço ao redor da ferida. Rigidez duradoura ocorre em cerca de 8,6% das pessoas, e demora na cicatrização da ferida em 1,2%. Problemas graves, como lesão de nervo ou infecção profunda, são incomuns: lesão de nervo ou dormência duradoura ocorre em 0,6%, e infecção do local cirúrgico em 2,1%. Cerca de 1 em cada 200 dedos precisa de uma segunda cirurgia, e o gatilho volta em 2,2%.

Alguns fatores influenciam o seu prognóstico. Se a articulação do meio do dedo já doía havia muito tempo antes do tratamento, essa dor articular pode não melhorar completamente mesmo depois da liberação da polia. Liberar vários dedos de uma vez tende a causar mais dor e rigidez no pós-operatório do que liberar apenas um dedo. E as pessoas que fazem a cirurgia até um mês depois de uma injeção de cortisona têm maior chance de infecção da ferida depois, o que vale a pena levar em conta na escolha do momento.

Se o seu dedo ficar quente, vermelho, inchado e dolorido, especialmente com febre, vá ao pronto-socorro no mesmo dia. Se os seus sintomas não estiverem melhorando, estiverem piorando ao longo de semanas, acordarem você à noite ou impedirem você de trabalhar ou de usar a mão, consulte o seu médico de família ou peça uma avaliação com especialista.

Quando procurar ajuda médica

Consulte o seu médico de família ou peça uma avaliação com especialista se o seu dedo ou polegar enganchar, travar na posição dobrada ou precisar da outra mão para ser esticado. O mesmo vale se você tiver um nódulo sensível na palma da mão que se move junto com o tendão, ou se o enganchamento estiver impedindo você de segurar objetos, trabalhar ou dormir. Se mais de um dedo apresentar gatilho, mencione isso também, pois pode indicar uma condição subjacente, como o diabetes. Isso é ainda mais importante em uma criança: gatilho em mais de um dedo ou polegar, ou gatilho acompanhado de formigamento ou dormência, exige uma avaliação com especialista, e não uma conduta de esperar para ver. Vá ao pronto-socorro no mesmo dia se o seu dedo ficar quente, vermelho, inchado e dolorido, especialmente com febre, ou se os seus dedos ficarem pálidos, frios, brancos ou azulados.

Em maior profundidade

Advanced reading: the deeper science (optional)

Esta seção aborda conteúdos além do necessário para suas próprias decisões de tratamento. O dedo em gatilho merece essa leitura adicional, pois o tratamento de primeira linha tem eficácia pouco superior a 50%, valor raramente mencionado; além disso, em crianças o mesmo quadro clínico tem significado suficientemente diferente para exigir investigações distintas.

A injeção funciona, e o número real é 57%

A injeção de corticosteroide é a intervenção padrão de primeira linha, sendo geralmente descrita simplesmente como eficaz. Os dados agregados de estudos de nível I e II são mais precisos: as injeções de corticosteroide são eficazes em 57% dos pacientes com dedo em gatilho. Apesar das limitações dos estudos incluídos, esse tratamento continua sendo recomendado como primeira opção, devido à sua simplicidade e ao alívio dos sintomas [1].

É importante conhecer esse percentual de 57% antes de optar pela injeção. Ele ajuda a enxergar uma segunda aplicação ou a decisão de recorrer à cirurgia como algo esperado para uma parcela considerável dos pacientes, e não como um fracasso do tratamento.

A imobilização com talas é realmente uma alternativa viável, e o período de uso é mais longo do que a maioria imagina

Nos casos em que as injeções não são indicadas — como no diabetes, onde podem afetar o controle glicêmico —, o uso de órteses possui base científica razoável. Os estudos apontam de forma consistente que os resultados foram semelhantes independentemente de qual articulação foi imobilizada, sendo recomendado que uma única articulação seja imobilizada por 6 a 10 semanas [2].

Esse período de tempo é justamente o que as pessoas subestimam. Uma tala usada por apenas duas semanas não constitui, de fato, um teste adequado de imobilização.

Liberação cirúrgica: o debate sobre a técnica já foi resolvido; a questão do método ainda permanece

A liberação da polia A1 pode ser feita de forma aberta, por meio de uma pequena incisão sob visão direta, ou percutaneamente, usando uma agulha ou lâmina. Em um estudo com 548 pacientes, não houve diferença significativa entre as técnicas aberta e percutânea no que diz respeito à necessidade de revisão cirúrgica, complicações ou dor pós-operatória; portanto, ambas são métodos adequados [3].

Uma análise mais ampla envolvendo 2.114 dedos demonstrou que a liberação percutânea é eficaz e segura; além disso, foram identificados dois pontos importantes: a orientação por ultrassom pode aumentar a taxa de sucesso, enquanto as taxas de sucesso não foram influenciadas nem pelo instrumento utilizado nem pela administração concomitante de cortisona [4]. Uma revisão de 2025 com 685 pacientes constatou que a combinação de liberação percutânea com injeção de corticosteroide foi bem tolerada, apresentando baixa taxa de complicações [5].

Em resumo: é necessário dividir a polia; contudo, o método empregado é menos importante do que garantir que a divisão seja feita de forma completa. O instrumento utilizado não determina o resultado final.

Em uma criança, o mesmo achado clínico exige uma conduta diferente

O dedo em gatilho pediátrico não é simplesmente a forma infantil da condição observada em adultos. A presença de dedos em gatilho bilaterais ou múltiplos, ou ainda de síndrome do túnel do carpo concomitante, deve levantar a suspeita de uma patologia subjacente atípica, como a mucopolissacaridose [6].

Este é, sem dúvida, o ponto de maior relevância clínica nesta seção. Uma criança com mais de um dedo em gatilho, ou com gatilho associado a sintomas neurológicos, deve ser submetida a investigações para detecção de algum distúrbio de armazenamento sistêmico, em vez de receber apenas um procedimento de liberação simples; afinal, o achado na mão pode ser o primeiro sinal de um diagnóstico com implicações que vão muito além da mão. Já um único polegar em gatilho em uma criança saudável representa uma situação diferente e muito mais comum.

Referências

[1] Fleisch SB, Spindler KP, Lee DH. Injeções de corticosteroides no tratamento do dedo em gatilho: uma revisão sistemática de nível I e II. J Am Acad Orthop Surg. 2007;15(3):166-71. https://doi.org/10.5435/00124635-200703000-00006

[2] Lunsford D, Valdes K, Hengy S. Tratamento conservador do dedo em gatilho: uma revisão sistemática. J Hand Ther. 2019;32(2):212-21. https://doi.org/10.1016/j.jht.2017.10.016

[3] Casey JC, Daher M, Dworkin M, Cusano J, Garavito J, Gil JA. Fixação aberta versus percutânea do dedo em gatilho: meta-análise dos resultados clínicos. J Hand Surg Am. 2024;49(6):570-5. https://doi.org/10.1016/j.jhsa.2024.03.010

[4] Zhao J, Kan S, Zhao L, Wang Z, Long L, Wang J, et al. Liberação percutânea da primeira polia anular para o tratamento de dedos em gatilho: revisão sistemática e meta-análise das evidências atuais. J Hand Surg Am. 2014;39(11):2192-202. https://doi.org/10.1016/j.jhsa.2014.07.044

[5] Wen J, Syed B, Khalil R, Shehabat M, Alam M, Sedighi R, et al. Liberação percutânea da polia A1 associada à injeção de corticosteroides no tratamento do dedo em gatilho: revisão sistemática e meta-análise. J Orthop Surg Res. 2025;20(1). https://doi.org/10.1186/s13018-025-05776-2

[6] Wong AL, Wong MJ, Parker R, Wheelock ME. Apresentação e etiologia do dedo em gatilho em crianças: uma revisão sistemática. J Hand Surg Eur Vol. 2021;47(2):192-6. https://doi.org/10.1177/17531934211035642


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

Non-Operative Management

  • Female patients presenting with their first trigger finger have the highest rate of long-term treatment success after a single corticosteroid injection [1].
  • Factors associated with a worse outcome following a steroid injection were identified and should be considered when choosing the treatment of a trigger finger [4].
  • Surgical management may be the next best option in patients with trigger finger who continue to be symptomatic after a single injection [12].
  • Management of trigger finger with 2 steroid injections before surgery is the least costly treatment strategy [14].
  • Repeated corticosteroid injections for recurrent trigger finger should be considered in patients who prefer nonsurgical treatment, especially in those without factors predictive of failure [33].
  • Offering up to three corticosteroid injections before surgical release represents the most cost-effective contemporary strategy for trigger finger management from a current Medicare payer perspective [62].
  • A referenced trial found no differences in patient-reported outcomes for pain or function or in reduction of trigger finger severity at 52 weeks among splint alone, steroid alone, and combination treatments [60].
  • The authors of the referenced trial recommend splinting alone as the least invasive option for the treatment of adults with trigger finger [60].

Operative Management

  • Open trigger finger release is generally a low-risk procedure, although there is potential for complications, some requiring reoperation [2].
  • Percutaneous release of the trigger finger should be the treatment of choice for the established trigger finger with symptoms of more than 4 months' duration [3].
  • Surgical open release is the “gold standard” of trigger finger treatment because it allows more careful inspection of the surgical area and is highly effective with low complication rates [5].
  • Percutaneous trigger finger release can safely be performed on all digits, including the thumb, small fingers, and index fingers [13].
  • The study confirms the efficacy and safety of percutaneous trigger finger release but shows no clinical advantage in using pre- or postoperative ultrasonography [15].
  • Surgical release can be recommended as an adequate treatment with minimal morbidity for any grade of trigger finger or thumb with failed non-operative treatment and for severe (Grade IV) trigger digits [16].
  • Patients who undergo open trigger finger release surgery in the clinic have complication rates similar to reported complication rates of surgery performed in the operating room [17].
  • Percutaneous release is permanent, safe, and cost-effective and should be considered as first-line treatment for demonstrable trigger fingers [18].
  • The authors recommend open surgery for trigger finger and trigger thumb, citing excellent long-term results with no recurrence and no serious complications such as nerve transection or bowstringing [49].
  • Procedure room-based treatment of trigger finger is less costly than release in the operating room [73].
  • The percutaneous technique using a L15 blade is recommended for trigger finger release because of lower costs and quicker procedure with equal functional outcome when compared with open surgery [97].

Surgical Technique

  • Local anesthetic infiltration in the palm proximal to the incision site is preferred for trigger finger release [20].
  • A transverse incision about 2 cm long several millimeters distal to the distal palmar crease is used for middle, ring, and small trigger finger releases [20].
  • A transverse incision about 2 cm long several millimeters distal to the proximal palmar crease is used for index trigger finger releases [20].
  • Trigger thumb releases can be done through incisions either distal or proximal to the metacarpophalangeal joint flexion crease [20].
  • The digital nerves on the thumb are more palmar and closer to the flexor sheath than might be anticipated, with the thumb radial digital nerve being especially vulnerable [20].
  • Trigger thumbs require release of only the A1 pulley, whereas trigger digits require division of the A1 and A0, or proximal palmar pulley [20].
  • For trigger thumb release, the surgeon should avoid cutting too far distally and disrupting the oblique pulley [20].
  • The tendon sheath is incised from proximal to distal, approximately 1 cm, and reassessed for triggering [20].
  • Persistent triggering after initial release implies that either the A1 and palmar pulleys are incompletely released or an alternate site of triggering is present [20].
  • When the distal A1 pulley edge is released, the divided pulley leaves are parallel rather than ending in a V-shaped pattern [20].
  • The compression dressing is removed after 48 hours and sutures are removed at 10 to 14 days postoperatively [20].
  • Normal use of the finger or thumb is encouraged after trigger finger release surgery [20].

Patient Preferences and Outcomes

  • Patients' preferences for trigger finger treatment often change after consulting with a hand surgeon and during treatment, but these choices do not affect treatment satisfaction [9].
  • Comparing patients and hand surgeons, there were some differences in treatment preferences and perceived advantages and disadvantages regarding idiopathic trigger finger [44].
  • These differences in treatment preferences between patients and hand surgeons might be addressed by a decision aid [44].

Safety and Complications

  • Ultrasound-assisted percutaneous trigger finger release raises questions regarding the safety and efficacy of the procedure, even when adding ultrasound guidance [7].
  • Patients with more lifetime trigger fingers and/or prior TFRs for other fingers are more likely to need ulnar superficialis slip resection during trigger finger release [34].
  • Patients who are more likely to need ulnar superficialis slip resection may benefit from hand therapy [34].

Anatomy & Pathophysiology

Demographics and Epidemiology

  • Trigger finger occurs in 2% to 3% of the general population [24].
  • Women are more commonly affected than men [24].
  • The condition is most common in women older than 50 years of age [21, 22].
  • Middle and ring finger involvement is most common in adults [21, 22].
  • The digits are affected in the following order of decreasing prevalence: thumb, ring, long, little, and index [24].
  • Trigger finger is more common in patients with systemic diseases such as diabetes mellitus (10% to 20% lifetime incidence), hypothyroidism, sarcoidosis, rheumatoid arthritis, and septic tenosynovitis [24].
  • Stenosing tenosynovitis is more common in diabetic patients than in nondiabetic patients [23].
  • When multiple digits are involved, the possibility of diabetes should be considered [23].
  • Trigger finger is associated with diabetes and inflammatory arthropathy [21, 22].
  • A clear difference exists between trigger thumbs and trigger fingers, with thumbs being more frequently affected [6].

Etiology and Pathogenesis

  • The precise etiology of trigger finger has not been elucidated [127].
  • Repetitive finger movements and local trauma are proposed causes of trigger finger [127].
  • Stress and degenerative force account for an increased incidence of trigger finger in the dominant hand [127].
  • Trigger finger is possibly associated with repetitive grasping activities [21, 22].
  • The causes of trigger finger are multiple and in each individual often multifactorial [127].
  • In patients with gout, monosodium urate precipitation elicits a fulminant inflammatory reaction in the tenosynovium [24].
  • In patients with calcific tendinitis, calcium salt deposition in the tenosynovium can result in triggering [24].
  • In patients with pseudogout, calcium pyrophosphate dihydrate crystal deposition is often localized to the triangular fibrocartilage or within the carpal tunnel [24].
  • In patients with amyloidosis, beta-2-microglobulin deposits in thick, plaque-like accumulations along the flexor tendons [24].
  • Amyloidosis is most commonly seen in patients with renal failure who are undergoing peritoneal dialysis or hemodialysis [24].
  • Trigger thumb in adults is a distinctly separate entity from “congenital” trigger thumb [36].
  • Stenosing tenosynovitis leading to inability to extend the flexed digit or flex the extended digit often produces a palpable “triggering” and usually is seen in individuals older than 45 years of age [36].
  • When associated with a collagen disease, several fingers may be involved, most often the long and ring fingers [36].
  • Trigger finger is an atraumatic medical phenomenon [5].

Histology and Pathology

  • Histology of trigger finger shows fibrocartilaginous metaplasia of the pulley and/or FDS tendon [21, 22].
  • Pathologic examination of the affected pulleys demonstrates a proliferation of chondrocytes and increased type III collagen [24].
  • The flexor digitorum profundus tendon will often demonstrate a pathologic nodule, while the flexor digitorum superficialis is often unaffected [24].
  • The lump in the palm may be the thickened area in the first annular pulley or a nodule or fusiform swelling of the flexor tendon just distal to it [36].
  • The tendon nodule usually is just proximal to the anulus at the metacarpophalangeal joint level [36].
  • In a rheumatoid patient, a nodule distal to the metacarpophalangeal joint level may cause triggering [36].
  • In trigger digits, fragmentation of the gliding surface of the A1 pulley is probably a result of anomalous friction forces during flexion-extension movements [136].
  • Congenital trigger digit involves narrowing and thickening of the sheath, with occasional formation of a ganglion cyst [123].
  • An intratendinous nodule may be present proximal to the first annular pulley in congenital trigger digit, often referred to as Notta’s nodule [123].
  • Chronic inflammation is frequent in congenital trigger digit [123].

Clinical Presentation and Classification

  • Trigger finger is characterized by pain and tenderness in the palm at the proximal edge of the digital A1 pulley [23].
  • Patients frequently note catching or triggering of the affected finger or thumb after forceful flexion [23].
  • In more severe cases, the opposite hand must be used to force the finger or thumb passively into extension [23].
  • In the most severe cases, the finger becomes locked in a flexed position [23].
  • Triggering is often more pronounced in the morning than later in the day [23].
  • Pain and tenderness in the distal palm progress to mechanical catching/locking, and may become fixed [21, 22].
  • A common complaint is referred pain at the dorsal MCP/PIP area [21, 22].
  • Concomitant trigger finger and carpal tunnel syndrome occurs in 40% to 60% of patients [21, 22].
  • Physical examination findings may include tenderness to palpation of the flexor tendon at the level of the A1 pulley [24].
  • Physical examination findings may include palpable triggering/pain with flexion and extension of the finger [24].
  • Physical examination findings may include nodularity of the flexor tendon just proximal to the A1 pulley [24].
  • Physical examination findings may include the presence of a volar retinacular ganglion cyst between the A1 and A2 pulleys [24].
  • Physical examination findings may include the presence of a fixed flexion deformity of the proximal interphalangeal (PIP) joint [24].
  • Green classification Grade I is defined as pain over the A1 pulley [21, 22, 24].
  • Green classification Grade II is defined as mechanical catching of the digit without locking [21, 22, 24].
  • Green classification Grade III is defined as mechanical locking of the digit which is passively correctable [21, 22, 24].
  • Green classification Grade IV is defined as a fixed locked finger [21, 22, 24].
  • Patients may experience triggering after operative release because of catching of the tendon on the palmar aponeurosis transverse fibers [36].
  • Triggering after operative release due to palmar aponeurosis catching usually resolves with time [36].
  • Occasionally, a partially lacerated flexor tendon at the metacarpophalangeal level heals with a nodule sufficiently large to cause triggering [36].
  • Local tenderness may be present but is not a prominent complaint in trigger finger [36].
  • Pressure accentuates the apparent snapping or triggering of the more distal joints [36].
  • Patients frequently state that the problem is in the proximal interphalangeal joint with trigger finger or in the proximal interphalangeal joint with trigger thumb [36].
  • Other conditions, such as intraarticular disorders and common extensor tendon subluxation, can cause similar symptoms and must be considered to determine effective treatment for idiopathic trigger finger [36].
  • Trigger finger is a very common condition in which a finger gets stuck at the level of the palm [69].
  • The finger may click, catch, or may not bend completely to the palm [69].

Anatomical Variations and Associations

  • Newer evidence has found a fourth pulley (variable annular pulley) in 75% of patients with trigger thumb, which may contribute to stenosis [21, 22].
  • Anatomical studies have identified two annular and one oblique pulley in the thumb [109].
  • A clear distinction should always be made between “trigger wrist” and “trigger finger at the wrist” [30].
  • Trigger finger at the wrist can be caused by an anomalous flexor digitorum superficialis muscle belly within the carpal tunnel [30].
  • Patients with greater volar migration of the flexor tendons after carpal tunnel release are at a higher risk of developing trigger finger [145].
  • A relationship between carpal tunnel release and trigger finger is possible, related to anatomy and biomechanics modifications after CTR (e.g. possible volar migration of the flexor tendons) and/or to a coexisting disorder [99].
  • The incidence of concurrent Dupuytren’s disease and trigger finger was observed in 16% of trigger finger cases [119].
  • When considering middle and ring fingers only, Dupuytren’s disease and trigger finger were present in 25% of cases [119].
  • If three additional cases were included where Dupuytren’s disease developed within 1 year after surgery for trigger finger, the incidence would be 28% [119].
  • The percentage of patients with combined trigger finger and Dupuytren’s disease strongly increases with age [83].
  • 50% of patients in the “80+” age group with trigger finger are suffering from both diseases [83].
  • Smith considers trigger finger as an early indication of Dupuytren’s disease [135].
  • In the extended finger position, thickening of the pulley wall leads to narrowing of the A1 pulley and synovial congestion [135].
  • The additional mechanical irritation of the Dupuytren’s cord above the A1 pulley may provoke an aggravation of the irritation [135].
  • In more progressed stages of Dupuytren’s contracture (Stages II or III), the concomitant appearance of trigger finger and Dupuytren’s contracture is rarely seen [135].
  • Advanced extension deficit reduces the range of motion of the tendon and thus causes less mechanical irritation at A1 [135].
  • The tendon becomes slightly thinner distal to the chiasm of the deep and superficial flexor tendon [135].

Pediatric Anatomy and Pathophysiology

  • Congenital trigger digit occurs when the normal gliding movement of the flexor tendon is impeded within the digital flexor sheath [123].
  • In contrast to the situation in adults with stenosing tenosynovitis, the congenitally involved finger usually shows a persistent flexion deformity, rather than actual "triggering" [123].
  • Congenital trigger digit is a relatively rare condition (2.3%) [123].
  • Congenital trigger digit occurs far more commonly in the thumb and is bilateral in about 25% of patients [123].
  • The condition occurs sporadically and is not believed to be an inherited trait [123].
  • Trigger digits typically occur without other anomalies, but an association with trisomy 13 has been reported [123].
  • An association with mucopolysaccharidosis has also been described [123].
  • Trigger digits in children are more commonly acquired; 25% are noted at birth [123].
  • A prospective study of 5765 newborns did not reveal a single case of congenital trigger thumb [123].
  • The condition is frequently not noted until age 1 or 2 years, at which time the child has a relatively fixed flexion posture of the interphalangeal joint of the thumb [123].
  • Even with some force, it may be impossible to extend the interphalangeal joint of the thumb fully [123].
  • The abnormal clicking or snapping usually is not the presenting complaint as seen in adults [123].
  • This condition must be differentiated from the clasped thumb deformity, in which there is primarily metacarpophalangeal flexion [123].
  • Fixed contractures are unlikely if the condition resolves or is corrected before the child is 3 years old [123].
  • Spontaneous resolution occurs in about 30% of children in whom the condition appears within the first year of life [123].
  • Spontaneous resolution occurs in about 12% of children in whom it appears between 6 months and 2 years of age [123].
  • Baek et al. noted spontaneous resolution in 63% over a median of 48 months [123].
  • Trigger finger is not often associated with a fixed flexion deformity in children [123].
  • Trigger finger in children may not respond to a simple A-pulley release [123].
  • When surgical intervention for pediatric trigger finger is undertaken, the surgeon should be prepared for a more extensive exploration of the flexor mechanism, which may include excision of one or both slips of the flexor digitorum superficialis tendon and release of the A3 pulley [123].
  • In children, trigger finger is distinctly different from trigger thumb, being rarer and not often associated with a fixed flexion contracture [146].
  • None of the congenital trigger thumbs resolved spontaneously, whereas two trigger fingers recovered without operation [6].

Classification

  • The Green classification system categorizes trigger finger into four grades based on clinical presentation [21].
  • Grade I trigger finger is defined as pain and tenderness at the A1 pulley [21].
  • Grade II trigger finger is defined as catching of the finger [21].
  • Grade III trigger finger is defined as locking of the finger that is passively correctable [21].
  • Grade IV trigger finger is defined as a fixed, locked finger [21].
  • The Quinnel grading system includes grades I, II, III, and IV for trigger finger [129].
  • The modified Green classification includes grades 0, 1, 2, and 3 for triggering [64].
  • In a study of 302 fingers, 12% were classified as grade I, 13% as grade II, and 75% as grade III [47].
  • There was no statistically significant difference between Green grades I, II, and III regarding the percentage of fingers successfully treated with injection [47].
  • In a study of 90 trigger digits, severity was graded according to Green's classification, with Grade I and II grouped as mild triggering and Grade III and IV grouped as severe triggering [63].
  • The Quinnel classification is used to assess trigger finger severity in the context of ultrasound-guided acupotomy [134].
  • Two distinct clinical types of trigger digits exist: nodular and diffuse [104].

Clinical Presentation

  • Trigger finger is defined as stenosing tenosynovitis of the flexor tendons with mechanical impingement of the flexor tendons at the A1 pulley [24].
  • Women are more commonly affected by trigger finger than men [24].
  • Trigger finger is more common in patients with systemic diseases such as diabetes mellitus, hypothyroidism, sarcoidosis, rheumatoid arthritis, and septic tenosynovitis [24].
  • Gout can present with marked pain, erythema, swelling, and warmth that mimics infectious tenosynovitis [24].
  • Calcific tendinitis can result in triggering and is affected five times more frequently in males than females [24].
  • Pseudogout involves calcium pyrophosphate dihydrate crystal deposition often localized to the triangular fibrocartilage or within the carpal tunnel [24].
  • Amyloidosis is characterized by the deposition of beta-2-microglobulin in thick, plaque-like accumulations along the flexor tendons and is most commonly seen in patients with renal failure undergoing dialysis [24].
  • Physical examination findings may include palpable triggering or pain with flexion and extension of the finger [24].
  • A clinical diagnosis of trigger finger is defined as a history of triggering or locking of a finger with or without pain and tenderness or swelling at the A1 pulley [61].
  • Patients may note a lump or knot in the palm, which may be the thickened area in the first annular pulley or a nodule or fusiform swelling of the flexor tendon just distal to it [36].
  • The tendon nodule can be palpated by the examiner’s fingertip and moves with the tendon [36].
  • Patients may experience triggering after operative release because of catching of the tendon on the palmar aponeurosis transverse fibers, which usually resolves with time [36].
  • Occasionally, a partially lacerated flexor tendon at the metacarpophalangeal joint level heals with a nodule sufficiently large to cause triggering [36].
  • Local tenderness may be present but is not a prominent complaint [36].
  • Pediatric trigger finger is a distinct ailment from adult trigger finger, and a secondary cause must be sought whenever long fingers are affected [55].
  • Acute trigger finger caused by partial flexor tendon injury is an uncommon but well-documented presentation [58].
  • Ultrasonography can detect various lesions in clinical trigger fingers, and some ultrasonographic findings correlated with clinical findings [59].

Investigations

Clinical Assessment and Classification

  • Pain and tenderness at the A1 pulley characterizes Grade I trigger finger [21, 22].
  • Mechanical catching of the digit without locking characterizes Grade II trigger finger [21, 22].
  • Mechanical locking of the digit which is passively correctable characterizes Grade III trigger finger [21, 22].
  • A fixed locked finger characterizes Grade IV trigger finger [21, 22].
  • Tenderness to palpation of the flexor tendon at the level of the A1 pulley is a physical examination finding [24].
  • Palpable triggering or pain with flexion and extension of the finger is a physical examination finding [24].
  • Nodularity of the flexor tendon just proximal to the A1 pulley is a physical examination finding [24].
  • The presence of a volar retinacular ganglion cyst between the A1 and A2 pulleys is a physical examination finding [24].
  • The presence of a fixed flexion deformity of the proximal interphalangeal (PIP) joint is a physical examination finding [24].
  • Observing the triggering of the digit guides the patient's treatment and assists in diagnosing trigger finger [39].

Imaging

  • Thickening and hypervascularization of the A1 pulley are the hallmarks of trigger fingers on sonography [130].
  • Ultrasound can detect various lesions in clinical trigger fingers, and some ultrasound findings correlated with clinical findings [59].
  • Advanced imaging is critical for identifying bony prominences causing locking when common etiologies are absent [120].

Treatment

Non-Operative Management

  • Corticosteroid injections are effective in 57% of patients with trigger finger [8].
  • A single corticosteroid injection for trigger finger has a 45% long-term success rate [31].
  • Steroid injections were an effective first-line intervention for the treatment of trigger finger [43].
  • The current evidence supports the use of corticosteroid injection as a first-line treatment for trigger finger [67].
  • A prospective, controlled, double-blind trial showed that steroid injection is a satisfactory treatment for trigger finger in 60% of patients [88].
  • Thirty-nine percent of second and third corticosteroid injections for trigger finger yield long-term relief [46].
  • Trigger finger patients with metabolic syndrome are at risk of poorer functional outcomes and treatment failure after a single corticosteroid injection than age- and sex-matched controls [11].
  • Diabetic patients are generally less responsive to corticosteroid injection for trigger finger [21, 22].
  • There is no difference between soluble and insoluble corticosteroid preparations for the treatment of trigger finger [21, 22].
  • Splinting is an effective short-term conservative treatment for trigger finger, offering symptom relief and functional improvement comparable to corticosteroid injections [45].
  • Orthoses are effective for non-surgical management of pediatric and adult trigger finger using various orthotic options [89].
  • Initiating conservative treatment with the MCP joint blocking splint has value for patients with trigger finger and positive outcomes in 77% of subjects, whereas use of the DIP joint splint was effective in about half of subjects [87].
  • A randomized clinical trial found no differences in patient-reported outcomes for pain or function or in reduction of trigger finger severity at 52 weeks among splint alone, steroid alone, and combination treatments [60].
  • The use of an injection without lidocaine is recommended to treat trigger finger [86].

Operative Management

  • Open surgical release of the A1 pulley effectively alleviates the subjective and objective manifestations of trigger finger and remains the benchmark procedure [91].
  • Surgical release of the A1 pulley provides satisfactory results in >90% of patients [24].
  • Approximately 97% of patients have complete resolution after operative treatment for trigger finger [36].
  • Open release is an effective treatment for trigger finger with limited need for nonprescription drugs, since almost all patients reported full resolution of triggering within 6 weeks, and analgesic use was minimal [74].
  • A study confirms the efficacy and safety of percutaneous trigger finger release but shows no clinical advantage in using pre- or postoperative ultrasonography [15].
  • While the clinical significance of findings regarding ultrasound-assisted percutaneous release is unclear, it raises questions regarding the safety and efficacy of percutaneous trigger finger release, even when adding ultrasound guidance [7].
  • In patients with rheumatoid arthritis, the preference is to excise a slip of the FDS tendon rather than to release the A1 pulley, because these patients are at risk for ulnar drift at the MCP joint [21, 22].
  • The radial digital nerve is at risk of iatrogenic injury during thumb trigger finger release, given its superficial location [21, 22].
  • Minor complications of open trigger finger release include wound dehiscence, scar tenderness, and decreased range of motion [21, 22].
  • Management of diabetic trigger finger with immediate surgical release in the clinic is the most cost-effective treatment strategy, assuming a corticosteroid injection failure rate of at least 34% [90].
  • The incidence and treatment outcome of cases in which trigger finger occurred in conjunction with Dupuytren's disease appeared less predictable than that of ordinary trigger finger [48].

Complications

Open Surgical Release

  • Major complications following trigger finger release are unlikely; however, minor complications are prominent [71].
  • About 1 in 20 fingers will experience a mild, transient adverse event after surgical release of the A1 pulley for idiopathic trigger finger [72].
  • About 1 in 200 fingers have a second surgery after surgical release of the A1 pulley for idiopathic trigger finger [72].
  • Incomplete pulley release and damage to the flexor tendons and digital nerves, especially in the index finger and thumb, remain of some concern with limited exposure techniques [36].
  • The recurrence rate for surgical treatment of trigger finger was 3%, with only a single patient requiring reoperation in a long-term follow-up study [76].
  • No nerve injuries, tendon bowstringing, or ulnar deviation of the digits were observed in a long-term follow-up study of surgical treatment for trigger finger [76].
  • There were no wound infections in a long-term follow-up study of surgical treatment for trigger finger [76].
  • Open surgery for trigger finger and trigger thumb has been associated with excellent long-term results with no recurrence and no serious complications such as nerve transection or bowstringing [49].
  • In patients with rheumatoid arthritis, release of the A1 pulley carries a chance that ulnar drift at the MCP joint can be exacerbated [21].
  • Triggering after operative release can occur because of catching of the tendon on the palmar aponeurosis transverse fibers, which usually resolves with time [36].
  • Occasionally, a partially lacerated flexor tendon at the A1 pulley level heals with a nodule sufficiently large to cause triggering [36].
  • Proximal interphalangeal joint pain in trigger finger patients results from long symptom duration and consequent joint pathology, and is incompletely resolved after A1 pulley release, leading to worse surgical outcomes than expected [25].
  • Physicians should consider the duration of preoperative symptoms and preoperative flexion contracture of the PIP joint when deciding timing of surgery for trigger finger patients [28].
  • Patients with more lifetime trigger fingers and/or prior trigger finger releases for other fingers are more likely to need ulnar superficialis slip resection [34].
  • Overall, 2.9% of patients underwent subsequent treatment in the same digit after initial trigger finger release [112].
  • Overall, 37.3% of patients underwent subsequent treatment in another digit after initial trigger finger release [112].
  • Smoking and higher comorbidity were independently associated with subsequent treatment in an additional finger after initial trigger finger release [112].
  • Patients with a higher BMI were less likely to require subsequent treatment in the digit initially released [112].
  • In a cohort of 3,428 patients who underwent trigger finger release, 16% experienced a complication [112].
  • In a cohort of 3,428 patients who underwent trigger finger release, 7% experienced a complication requiring either antibiotics, further steroid injection, or pharmacologic treatments [112].
  • In a cohort of 3,428 patients who underwent trigger finger release, 2.2% required some form of surgical intervention [112].
  • In a study of 795 digits released, the incidence of reoperation was 2.4% [112].
  • There were no significant differences in scar quality or improvement in patient-reported disability with transverse or longitudinal incisions for trigger finger release [70].

Percutaneous Release

  • Trigger digits were successfully treated in 100% of the cases using the percutaneous technique in a prospective randomized trial [116].
  • A greater risk of lesion to the neurovascular sheath exists with the percutaneous release of the thumb and small finger [81].

Corticosteroid Injection

  • Corticosteroid injections may elevate serum glucose levels for 5 days or more in patients with diabetes mellitus [36].
  • Preoperative hypoglycemia increased infection risk after trigger finger injection and release [19].
  • There were no complications from injection and no patient was made worse in a study of 302 fingers treated with steroid injection [47].

Combined Pathologies

  • In cases of trigger finger combined with Dupuytren's disease where Dupuytren's tissue was resected, 58% developed a recurrence with induration in the operated area within 1 year [54].
  • Patients with trigger finger combined with Dupuytren's disease who underwent resection of Dupuytren's tissue reported problems in flexion of the fingers with permanent tension in the finger as a result of ongoing irritation reactions for months after the operation [54].

Recovery

Non-Operative Recovery

  • A single corticosteroid injection for trigger finger has a 45% long-term success rate, with success beyond two years likely predicting lasting symptom relief [31].
  • Although symptomatic resolution of trigger finger from a single corticosteroid injection can occur early on, a followup of 4 weeks (28 days) does not allow enough time for symptom resolution [27].
  • A dose-response characteristic was demonstrated in the treatment of trigger finger with triamcinolone acetonide [153].
  • Patients with marked triggering, symptoms of more than 6 months' duration, and multiple involved digits had a higher rate of failure in both groups [154].

Operative Recovery

  • This large retrospective series suggests that about 1 in 20 fingers will experience a mild, transient adverse event after surgical release of the A1 pulley for idiopathic trigger finger and that about 1 in 200 have a second surgery [72].
  • Percutaneous A1 pulley release is more effective medium-term therapy for trigger digit than steroid injection, because of lower risk of recurrence [75].
  • Simultaneous steroid injection at the time of surgical release provides greater subjective improvement in the early period after percutaneous trigger finger release [148].
  • Symptom relief period after open A1 pulley release for trigger fingers was positively correlated with preoperative symptom duration and number of preoperative corticosteroid injections [152].
  • Patients with more lifetime trigger fingers and/or prior TFRs for other fingers are more likely to need USSR, and these patients may benefit from hand therapy [34].

Key Evidence

  • [L4] Female patients presenting with their first trigger finger have the highest rate of long-term treatment success after a single corticosteroid injection. [1] (10.2106/jbjs.n.00004)
  • [L3] Open trigger finger release is generally a low-risk procedure, although there is potential for complications, some requiring reoperation. [2] (10.1007/s11552-014-9716-9)
  • [L3] This technique should be the treatment of choice for the established trigger finger with symptoms of more than 4 months' duration. [3] (10.1016/0363-5023(92)90125-9)
  • [L3] Factors associated with a worse outcome following a steroid injection were identified and should be considered when choosing the treatment of a trigger finger. [4] (10.1302/0301-620x.104b10.bjj-2022-0058.r3)
  • [L5] Surgical open release is the “gold standard” of trigger finger treatment because it allows more careful inspection of the surgical area and is highly effective with low complication rates. [5] (10.1142/s021881041750023x)
  • [L4] A clear difference exists between trigger thumbs and trigger fingers, with thumbs being more frequently affected and none resolving spontaneously, whereas two trigger fingers recovered without operation. [6] (10.1016/s0363-5023(96)80213-9)
  • [L5] While the clinical significance of these findings is unclear, it raises questions regarding the safety and efficacy of percutaneous trigger finger release, even when adding ultrasound guidance. [7] (10.1007/s11552-008-9137-8)
  • [L1] Corticosteroid injections are effective in 57% of patients with trigger finger. [8] (10.5435/00124635-200703000-00006)
  • [Paper] Patients' preferences for trigger finger treatment often change after consulting with a hand surgeon and during treatment, but these choices do not affect treatment satisfaction. [9] (10.1007/s12593-015-0203-5)
  • [L3] Trigger finger patients with metabolic syndrome are at risk of poorer functional outcomes and treatment failure after a single corticosteroid injection than age- and sex-matched controls. [11] (10.1016/j.jhsa.2016.07.091)
  • [L4] These data suggest that surgical management may be the next best option in patients with trigger finger who continue to be symptomatic after a single injection. [12] (10.1016/s0363-5023(05)80194-7)
  • [L5] Based on our findings, percutaneous trigger finger release can safely be performed on all digits, including the thumb, small fingers, and index fingers. [13] (10.1007/s11552-007-9069-8)
  • [L2] Management of trigger finger with 2 steroid injections before surgery is the least costly treatment strategy. [14] (10.1016/j.jhsa.2009.02.029)
  • [L4] The study confirms the efficacy and safety of percutaneous trigger finger release but shows no clinical advantage in using pre- or postoperative ultrasonography. [15] (10.1177/1753193413517992)
  • [L4] Surgical release can be recommended as an adequate treatment with minimal morbidity for any grade of trigger finger or thumb with failed non-operative treatment and for severe (Grade IV) trigger digits. [16] (10.1016/j.jhsb.2007.02.016)
  • [L4] Patients who undergo open trigger finger release surgery in the clinic have complication rates similar to reported complication rates of surgery performed in the operating room. [17] (10.1016/j.jhsg.2022.01.008)
  • [L3] Percutaneous release is permanent, safe, and cost-effective and should be considered as first-line treatment for demonstrable trigger fingers. [18] (10.5435/jaaosglobal-d-25-00445)
  • [L4] Proximal interphalangeal joint pain in trigger finger patients results from long symptom duration and consequent joint pathology, and is incompletely resolved after A1 pulley release, leading to worse surgical outcomes than expected. [25] (10.1177/1753193418809771)
  • [L3] Although symptomatic resolution of trigger finger from a single corticosteroid injection can occur early on, a followup of 4 weeks (28 days) does not allow enough time for symptom resolution. [27] (10.1142/s2424835518500364)
  • [L4] Physicians should consider the duration of preoperative symptoms and preoperative flexion contracture of the PIP joint when deciding timing of surgery for trigger finger patients. [28] (10.1016/j.jhsa.2018.06.023)
  • [L5] A clear distinction should always be made between “trigger wrist” and “trigger finger at the wrist”. [30] (10.1016/j.main.2007.08.004)
  • [L5] This commentary highlights that a single corticosteroid injection for trigger finger has a 45% long-term success rate, with success beyond two years likely predicting lasting symptom relief, though results vary by sex and number of affected digits. [31] (10.2106/jbjs.n.00832)
  • [L2] Repeated corticosteroid injections for recurrent trigger finger should be considered in patients who prefer nonsurgical treatment, especially in those without factors predictive of failure. [33] (10.1016/j.jhsa.2023.12.002)
  • [L3] Patients with more lifetime trigger fingers and/or prior TFRs for other fingers are more likely to need USSR, and these patients may benefit from hand therapy. [34] (10.1016/j.jhsa.2024.08.013)
  • [L4] Observing the triggering of the digit guides the patient's treatment, and the outlined technique assists in diagnosing and treating one of the most common hand conditions seen in practice. [39] (10.1016/j.jhsa.2011.12.014)
  • [L4] Steroid injections were an effective first-line intervention for the treatment of trigger finger. [43] (10.1016/j.jhsa.2014.09.006)
  • [L4] Comparing patients and hand surgeons, there were some differences in treatment preferences and perceived advantages and disadvantages regarding idiopathic trigger finger—differences that might be addressed by a decision aid. [44] (10.1016/j.jhsa.2014.08.010)
  • [L2] Splinting is an effective short-term conservative treatment for trigger finger, offering symptom relief and functional improvement comparable to corticosteroid injections. [45] (10.1016/j.jhsg.2025.100881)
  • [L4] Thirty-nine percent of second and third corticosteroid injections for trigger finger yield long-term relief. [46] (10.1016/j.jhsa.2017.02.001)
  • [L4] [47] (10.1016/0363-5023(90)90149-l)
  • [Textbook] The incidence and treatment outcome of cases in which trigger finger occurred in conjunction with Dupuytren's disease appeared less predictable than that of ordinary trigger finger. [48] (10.1007/978-3-642-22697-7_31)
  • [L4] The authors recommend open surgery for trigger finger and trigger thumb, citing excellent long-term results with no recurrence and no serious complications such as nerve transection or bowstringing. [49] (10.1007/s00402-008-0802-8)
  • [L4] Pediatric trigger finger is a distinct ailment from adult trigger finger, and a secondary cause must be sought whenever long fingers are affected. [55] (10.1177/1558944715627634)
  • [L4] Acute trigger finger caused by partial flexor tendon injury is an uncommon but well-documented presentation. [58] (10.1177/1558944716681950)
  • [L4] US can detect various lesions in clinical trigger fingers, and some US findings correlated with clinical findings. [59] (10.1007/s00296-009-1165-3)
  • [L5] The author notes that the referenced trial found no differences in patient-reported outcomes for pain or function or in reduction of trigger finger severity at 52 weeks among splint alone, steroid alone, and combination treatments, leading the trial authors to recommend splinting alone as the least invasive option. [60] (10.1097/corr.0000000000002726)
  • [L1] [61] (10.1136/ard.2007.073106)
  • [L2] Offering up to three corticosteroid injections before surgical release represents the most cost-effective contemporary strategy for trigger finger management from a current Medicare payer perspective. [62] (10.1016/j.jhsg.2026.101103)
  • [L4] [63] (10.4055/cios.2012.4.4.263)
  • [L4] [64] (10.1016/j.hansur.2016.02.004)
  • [L4] The current evidence supports the use of corticosteroid injection as a first-line treatment for trigger finger. [67] (10.1177/175899830701200304)
  • [L1] [69] (10.1177/15589447211058816)
  • [L2] There were no significant differences in scar quality or improvement in patient-reported disability with transverse or longitudinal incisions for trigger finger release. [70] (10.1177/1753193419859375)
  • [L3] Major complications following trigger finger release are unlikely; however, minor complications are prominent. [71] (10.1177/15589447221081869)
  • [L4] This large retrospective series suggests that about 1 in 20 fingers will experience a mild, transient adverse event after surgical release of the A1 pulley for idiopathic trigger finger and that about 1 in 200 have a second surgery. [72] (10.1016/j.jhsa.2012.05.014)
  • [L4] The study demonstrates that procedure room-based treatment of trigger finger is less costly than release in the OR. [73] (10.1097/gox.0000000000002509)
  • [L2] Open release is an effective treatment for trigger finger with limited need for nonprescription drugs, since almost all patients reported full resolution of triggering within 6 weeks, and analgesic use was minimal. [74] (10.1016/j.jhsa.2025.12.006)
  • [L1] Percutaneous A1 pulley release is more effective medium-term therapy for trigger digit than steroid injection, because of lower risk of recurrence. [75] (10.1177/1753193410381824)
  • [L4] [76] (10.1016/s0363-5023(05)80195-9)
  • [L1] [81] (10.1093/rheumatology/ker315)
  • [L1] We recommend the use of an injection without lidocaine to treat trigger finger. [86] (10.1016/j.jhsa.2018.06.090)
  • [L1] Initiating conservative treatment with the MCP joint blocking splint has value for patients with trigger finger and positive outcomes in 77% of subjects, whereas use of the DIP joint splint was effective in about half of subjects. [87] (10.1016/j.jhsa.2011.10.038)
  • [L1] Our prospective, controlled, double-blind trial showed that steroid injection is a satisfactory treatment for trigger finger in 60% of patients. [88] (10.1016/0266-7681(92)90014-s)
  • [L1] Orthoses are effective for non-surgical management of pediatric and adult trigger finger using various orthotic options. [89] (10.1016/j.jht.2023.05.016)
  • [L3] Management of diabetic trigger finger with immediate surgical release in the clinic is the most cost-effective treatment strategy, assuming a corticosteroid injection failure rate of at least 34%. [90] (10.1016/j.jhsa.2016.08.007)
  • [L5] Open surgical release of the A1 pulley effectively alleviates the subjective and objective manifestations of trigger finger and remains the benchmark procedure. [91] (10.5435/jaaos-d-19-00614)
  • [L1] Because of lower costs and quicker procedure with equal functional outcome when compared with open surgery, we recommend the percutaneous technique using a L15 blade for trigger finger release. [97] (10.1097/bth.0b013e31817f289a)
  • [L4] However, a relationship is possible, related to anatomy and biomechanics modifications after CTR (e.g. possible volar migration of the flexor tendons) and/or to a coexisting disorder (with the same etiology). [99] (10.1016/j.main.2015.03.003)
  • [L3] Two distinct clinical types of trigger digits exist—nodular and diffuse. [104] (10.1016/s0363-5023(89)80024-3)
  • [L5] Anatomical studies have identified two annular and one oblique pulley in the thumb. [109] (10.1016/s0363-5023(77)80101-9)
  • [L4] [112] (10.1016/j.jhsa.2025.02.009)
  • [L1] Trigger digits were successfully treated in 98% of the cases using the open surgical technique and in 100% of the cases using the percutaneous technique. [116] (10.1053/jhsu.2001.24967)
  • [L4] This case supports the inclusion of metacarpal head osteochondroma in the differential diagnosis of a 'trigger finger.' Advanced imaging is critical for identifying bony prominences causing locking when common etiologies are absent. [120] (10.1016/j.jhsg.2023.03.010)
  • [L5] [127] (10.1007/s12178-007-9012-1)
  • [L3] [129] (10.1097/bth.0000000000000231)
  • [L4] Thickening and hypervascularization of the A1 pulley are the hallmarks of trigger fingers on sonography. [130] (10.7863/jum.2008.27.10.1407)
  • [L1] [134] (10.1186/s13018-023-04127-3)
  • [L4] In the trigger digits, this fragmentation of the gliding surface is, probably, a result of anomalous friction forces during flexion-extension movements of the fingers between the pulley and the flexor tendons. [136] (10.1016/j.jhsb.2007.01.013)
  • [L3] Patients with greater volar migration of the flexor tendons after CTR are at a higher risk of developing trigger finger. [145] (10.1177/1753193413479506)
  • [L4] In children, trigger finger is distinctly different from trigger thumb, being rarer and not often associated with a fixed flexion contracture. [146] (10.1053/jhsu.1999.1156)
  • [L1] Simultaneous steroid injection at the time of surgical release provides greater subjective improvement in the early period after percutaneous trigger finger release. [148] (10.1177/1753193418813771)
  • [L4] Symptom relief period after open A1 pulley release for trigger fingers was positively correlated with preoperative symptom duration and number of preoperative corticosteroid injections. [152] (10.1016/j.jhsa.2017.06.087)
  • [L1] A dose-response characteristic was demonstrated in the treatment of trigger finger with triamcinolone acetonide. [153] (10.1142/s2424835518500157)
  • [L4] Patients with marked triggering, symptoms of more than 6 months' duration, and multiple involved digits had a higher rate of failure in both groups. [154] (10.1016/0363-5023(92)90124-8)

References

[1] Long-Term Outcomes Following a Single Corticosteroid Injection for Trigger Finger. Journal of Bone and Joint Surgery. 2014. DOI: 10.2106/jbjs.n.00004

[2] Risk Factors for Complications of Open Trigger Finger Release. HAND. 2014. DOI: 10.1007/s11552-014-9716-9

[3] Percutaneous release of the trigger finger: An office procedure. The Journal of Hand Surgery. 1992. DOI: 10.1016/0363-5023(92)90125-9

[4] Factors associated with conversion to surgical release after a steroid injection in patients with a trigger finger. The Bone & Joint Journal. 2022. DOI: 10.1302/0301-620x.104b10.bjj-2022-0058.r3

[5] Trigger Finger: An Atraumatic Medical Phenomenon. The Journal of Hand Surgery (Asian-Pacific Volume). 2017. DOI: 10.1142/s021881041750023x

[6] Congenital trigger digit. The Journal of Hand Surgery. 1996. DOI: 10.1016/s0363-5023(96)80213-9

[7] Ultrasound-Assisted Percutaneous Trigger Finger Release: Is it Safe?. HAND. 2008. DOI: 10.1007/s11552-008-9137-8

[8] Corticosteroid Injections in the Treatment of Trigger Finger: A Level I and II Systematic Review. Journal of the American Academy of Orthopaedic Surgeons. 2007. DOI: 10.5435/00124635-200703000-00006

[9] Early Patient Satisfaction with Different Treatment Pathways for Trigger Finger and Thumb. Journal of Hand and Microsurgery. 2015. DOI: 10.1007/s12593-015-0203-5

[11] Effect of Metabolic Syndrome on the Outcome of Corticosteroid Injection for Trigger Finger: Matched Case-Control Study. The Journal of Hand Surgery. 2016. DOI: 10.1016/j.jhsa.2016.07.091

[12] Injection versus surgery in the treatment of trigger finger. The Journal of Hand Surgery. 1997. DOI: 10.1016/s0363-5023(05)80194-7

[13] The Safety of Percutaneous Trigger Finger Release. HAND. 2007. DOI: 10.1007/s11552-007-9069-8

[14] Using Evidence to Minimize the Cost of Trigger Finger Care. The Journal of Hand Surgery. 2009. DOI: 10.1016/j.jhsa.2009.02.029

[15] A study of 60 patients with percutaneous trigger finger releases: clinical and ultrasonographic findings. Journal of Hand Surgery (European Volume). 2014. DOI: 10.1177/1753193413517992

[16] Outcome of Open Trigger Digit Release. Journal of Hand Surgery (European Volume). 2007. DOI: 10.1016/j.jhsb.2007.02.016

[17] Office-Based Open Trigger Finger Release Has a Low Complication Rate. Journal of Hand Surgery Global Online. 2022. DOI: 10.1016/j.jhsg.2022.01.008

[18] Percutaneous Release of Trigger Finger: Long-Term Review of Outcomes Using 18-Gauge Needle. JAAOS: Global Research and Reviews. 2026. DOI: 10.5435/jaaosglobal-d-25-00445

[19] Campbell S Operative Orthopaedics 4 Volume Set. EXCISION OF NECROTIC MUSCLES COMBINED WITH NEUROLYSIS OF MEDIAN AND ULNAR NERVES FOR SEVERE CONTRACTURE > REFERENCES > TRIGGER THUMB AND TRIGGER FINGER.

[20] Campbell S Operative Orthopaedics 4 Volume Set. EXCISION OF NECROTIC MUSCLES COMBINED WITH NEUROLYSIS OF MEDIAN AND ULNAR NERVES FOR SEVERE CONTRACTURE > TRIGGER FINGER AND THUMB > SURGICAL RELEASE OF TRIGGER FINGER.

[21] Miller S Review Of Orthopaedics. SECTION 16 PATELLAR TRACKING IN TOTAL KNEE ARTHROPLASTY > 2. Flexor tendon injury > 3. Stenosing tenosynovitis (trigger finger).

[22] Miller S Review Of Orthopaedics. 2. Flexor tendon injury > 3. Stenosing tenosynovitis (trigger finger).

[23] A Lange Medical Book Current Diagnosis Treatment In Orthopedics Fifth Edition. 9Hand Surgery > 2. Flexor Tenosynovitis (Trigger Finger and Trigger Thumb).

[24] Aaos Comprehensive Orthopaedic Review 3. Tendinopathy of the Hand and Wrist* > II. Trigger Finger.

[25] Clinical significance of proximal interphalangeal joint pain in patients with trigger fingers. Journal of Hand Surgery (European Volume). 2018. DOI: 10.1177/1753193418809771

[27] Establishing an Efficient Care Paradigm for Trigger Finger. The Journal of Hand Surgery (Asian-Pacific Volume). 2018. DOI: 10.1142/s2424835518500364

[28] Factors Causing Prolonged Postoperative Symptoms Despite Absence of Complications After A1 Pulley Release for Trigger Finger. The Journal of Hand Surgery. 2019. DOI: 10.1016/j.jhsa.2018.06.023

[30] “Trigger finger at the wrist” due to anomalous flexor digitorum superficialis muscle belly within the carpal tunnel. Chirurgie de la Main. 2007. DOI: 10.1016/j.main.2007.08.004

[31] Doc, Will This Injection Make My Trigger Finger Go Away?. Journal of Bone and Joint Surgery. 2014. DOI: 10.2106/jbjs.n.00832

[33] Factors Influencing the Successful Treatment of Recurrent Trigger Finger With Repeated Corticosteroid Injections: A Prospective Cohort Study. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2023.12.002

[34] Risk Factors for Requiring Ulnar Superficialis Slip Resection During Trigger Finger Release. The Journal of Hand Surgery. 2025. DOI: 10.1016/j.jhsa.2024.08.013

[36] Campbell S Operative Orthopaedics 4 Volume Set. EXCISION OF NECROTIC MUSCLES COMBINED WITH NEUROLYSIS OF MEDIAN AND ULNAR NERVES FOR SEVERE CONTRACTURE > TRIGGER FINGER AND THUMB.

[39] An Observation on Trigger Fingers. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2011.12.014

[43] Long-Term Effectiveness of Corticosteroid Injections for Trigger Finger and Thumb. The Journal of Hand Surgery. 2015. DOI: 10.1016/j.jhsa.2014.09.006

[44] Trigger Finger: Assessment of Surgeon and Patient Preferences and Priorities for Decision Making. The Journal of Hand Surgery. 2014. DOI: 10.1016/j.jhsa.2014.08.010

[45] Efficacy of Splinting in Managing Adult Trigger Finger: A Systematic Review of Short-Term Outcomes. Journal of Hand Surgery Global Online. 2026. DOI: 10.1016/j.jhsg.2025.100881

[46] Long-Term Effectiveness of Repeat Corticosteroid Injections for Trigger Finger. The Journal of Hand Surgery. 2017. DOI: 10.1016/j.jhsa.2017.02.001

[47] Treatment of trigger finger by steroid injection. The Journal of Hand Surgery. 1990. DOI: 10.1016/0363-5023(90)90149-l

[48] 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa. Dupuytren’s Disease and Related Hyperproliferative Disorders. 2012. DOI: 10.1007/978-3-642-22697-7_31

[49] Long-term results of surgical release of trigger finger and trigger thumb in adults. Archives of Orthopaedic and Trauma Surgery. 2009. DOI: 10.1007/s00402-008-0802-8

[54] Dupuytren S Disease And Related Hyperproliferative Disorders. 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa > 31.5 Discussion > 31.5.3 Surgical Strategies and Recommendations.

[55] Pediatric Trigger Finger due to Osteochondroma. HAND. 2016. DOI: 10.1177/1558944715627634

[58] Closed Partial Flexor Digitorum Profundus Rupture: An Unusual Cause of Pediatric Trigger Finger. HAND. 2016. DOI: 10.1177/1558944716681950

[59] Ultrasonographic assessment of clinically diagnosed trigger fingers. Rheumatology International. 2009. DOI: 10.1007/s00296-009-1165-3

[60] CORR Insights®: Are There Differences in Pain Reduction and Functional Improvement Among Splint Alone, Steroid Alone, and Combination for the Treatment of Adults With Trigger Finger?. Clinical Orthopaedics & Related Research. 2023. DOI: 10.1097/corr.0000000000002726

[61] Corticosteroid injections effective for trigger finger in adults in general practice: a double-blinded randomised placebo controlled trial. Annals of the Rheumatic Diseases. 2008. DOI: 10.1136/ard.2007.073106

[62] Cost-Effectiveness of Contemporary Trigger Finger Treatment Strategies: A Medicare Payer Perspective. Journal of Hand Surgery Global Online. 2027. DOI: 10.1016/j.jhsg.2026.101103

[63] The Efficacy of Steroid Injection in the Treatment of Trigger Finger. Clinics in Orthopedic Surgery. 2012. DOI: 10.4055/cios.2012.4.4.263

[64] Modified percutaneous trigger finger release. Hand Surgery and Rehabilitation. 2016. DOI: 10.1016/j.hansur.2016.02.004

[67] The Use Of Corticosteroid Injections In The Treatment Of Stenosing Tendovaginits (Trigger Finger): Three Comparative Case Studies. The British Journal of Hand Therapy. 2007. DOI: 10.1177/175899830701200304

[69] Patient Comprehension of Trigger Finger Concepts Based on Distribution Format: A Randomized Controlled Trial of Handout Versus Video. HAND. 2021. DOI: 10.1177/15589447211058816

[70] A prospective, randomized clinical trial of transverse versus longitudinal incisions for trigger finger release. Journal of Hand Surgery (European Volume). 2019. DOI: 10.1177/1753193419859375

[71] Complications Following Endoscopic and Open Trigger Finger Release: A Retrospective Comparative Study. HAND. 2022. DOI: 10.1177/15589447221081869

[72] Adverse Events of Open A1 Pulley Release for Idiopathic Trigger Finger. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2012.05.014

[73] A Cost and Efficiency Analysis of the WALANT Technique for the Management of Trigger Finger in a Procedure Room of a Major City Hospital. Plastic and Reconstructive Surgery - Global Open. 2019. DOI: 10.1097/gox.0000000000002509

[74] Patient-Reported Symptom Relief and Use of Analgesics After Open Release of Trigger Finger: A Prospective, Multicenter Cohort Study With 6 Months Follow-Up. The Journal of Hand Surgery. 2026. DOI: 10.1016/j.jhsa.2025.12.006

[75] Percutaneous A1 pulley release vs steroid injection for trigger digit: the results of a prospective, randomized trial. Journal of Hand Surgery (European Volume). 2010. DOI: 10.1177/1753193410381824

[76] The results of surgical treatment of trigger finger. The Journal of Hand Surgery. 1997. DOI: 10.1016/s0363-5023(05)80195-9

[81] Treatment of trigger finger: randomized clinical trial comparing the methods of corticosteroid injection, percutaneous release and open surgery. Rheumatology. 2011. DOI: 10.1093/rheumatology/ker315

[83] Dupuytren S Disease And Related Hyperproliferative Disorders. 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa > 31.5 Discussion.

[86] Trigger Finger Corticosteroid Injection With and Without Lidocaine—A Randomized, Double-Blind Controlled Trial. The Journal of Hand Surgery. 2018. DOI: 10.1016/j.jhsa.2018.06.090

[87] Trigger Finger Treatment: A Comparison of 2 Splint Designs. The Journal of Hand Surgery. 2012. DOI: 10.1016/j.jhsa.2011.10.038

[88] Controlled Study of the Use of Local Steroid Injection in the Treatment of Trigger Finger and Thumb. Journal of Hand Surgery. 1992. DOI: 10.1016/0266-7681(92)90014-s

[89] Orthotic intervention options to non-surgically manage adult and pediatric trigger finger: A systematic review. Journal of Hand Therapy. 2023. DOI: 10.1016/j.jht.2023.05.016

[90] Cost of Immediate Surgery Versus Non-operative Treatment for Trigger Finger in Diabetic Patients. The Journal of Hand Surgery. 2016. DOI: 10.1016/j.jhsa.2016.08.007

[91] Current Concepts in the Management of Trigger Finger in Adults. Journal of the American Academy of Orthopaedic Surgeons. 2020. DOI: 10.5435/jaaos-d-19-00614

[97] Open Versus Percutaneous Release of the A1-Pulley for Stenosing Tendovaginitis. Techniques in Hand & Upper Extremity Surgery. 2008. DOI: 10.1097/bth.0b013e31817f289a

[99] Is carpal tunnel release associated with trigger finger?. Chirurgie de la Main. 2015. DOI: 10.1016/j.main.2015.03.003

[104] Nonoperative treatment of trigger fingers and thumbs. The Journal of Hand Surgery. 1989. DOI: 10.1016/s0363-5023(89)80024-3

[109] Anatomy of the flexor tendon sheath and pulleys of the thumb. The Journal of Hand Surgery. 1977. DOI: 10.1016/s0363-5023(77)80101-9

[112] Incidence and Predictors of Subsequent Triggering Requiring Treatment After Trigger Finger Release. The Journal of Hand Surgery. 2026. DOI: 10.1016/j.jhsa.2025.02.009

[116] Prospective randomized trial of open versus percutaneous surgery for trigger digits. The Journal of Hand Surgery. 2001. DOI: 10.1053/jhsu.2001.24967

[119] Dupuytren S Disease And Related Hyperproliferative Disorders. 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa > 31.3 Patients Characteristics and Incidence of Concurrent Disease.

[120] Metacarpal Neck Osteochondroma: An Atypical Cause of “Trigger Finger”. Journal of Hand Surgery Global Online. 2023. DOI: 10.1016/j.jhsg.2023.03.010

[123] Campbell S Operative Orthopaedics 4 Volume Set. MULTIPLE Z-PLASTY RELEASE OF A CONGENITAL RING > TRIGGER FINGERS.

[127] Trigger finger: etiology, evaluation, and treatment. Current Reviews in Musculoskeletal Medicine. 2007. DOI: 10.1007/s12178-007-9012-1

[129] Open Surgery for Trigger Finger Required Combined a1-a2 Pulley Release. A Retrospective Study on 1305 Case. Techniques in Hand & Upper Extremity Surgery. 2019. DOI: 10.1097/bth.0000000000000231

[130] Sonographic Appearance of Trigger Fingers. Journal of Ultrasound in Medicine. 2008. DOI: 10.7863/jum.2008.27.10.1407

[134] Ultrasound-guided acupotomy for trigger finger: a systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research. 2023. DOI: 10.1186/s13018-023-04127-3

[135] Dupuytren S Disease And Related Hyperproliferative Disorders. 31. The Influence of Dupuytren’s Disease on Trigger Fingers and Vice Versa > 31.5 Discussion > 31.5.1 Why Is DD Concurring with TF?.

[136] Scanning Electron Microscopic Findings of the Gliding Surface of the A1 Pulley in Trigger Fingers and Thumbs. Journal of Hand Surgery (European Volume). 2007. DOI: 10.1016/j.jhsb.2007.01.013

[145] The relationship of trigger finger and flexor tendon volar migration after carpal tunnel release. Journal of Hand Surgery (European Volume). 2013. DOI: 10.1177/1753193413479506

[146] Trigger finger in children. The Journal of Hand Surgery. 1999. DOI: 10.1053/jhsu.1999.1156

[148] Effects of simultaneous steroid injection after percutaneous trigger finger release: a randomized controlled trial. Journal of Hand Surgery (European Volume). 2018. DOI: 10.1177/1753193418813771

[152] Factors of Delayed Symptom Relief after A1 Pulley Release for Trigger Fingers. The Journal of Hand Surgery. 2017. DOI: 10.1016/j.jhsa.2017.06.087

[153] Different Dosages of Triamcinolone Acetonide Injection for the Treatment of Trigger Finger and Thumb: A Randomized Controlled Trial. The Journal of Hand Surgery (Asian-Pacific Volume). 2018. DOI: 10.1142/s2424835518500157

[154] Trigger fingers and thumb: When to splint, inject, or operate. The Journal of Hand Surgery. 1992. DOI: 10.1016/0363-5023(92)90124-8

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.